Rep. Gilbert Ray Cisneros Jr. (D-CA) Buys Kenvue (KVUE) Stock

Democratic Representative Gilbert Ray Cisneros Jr. picked up shares of Kenvue Inc. KVUE in a trade valued between $1,001 and $15,000 on June 16, 2026. According to a periodic transaction report filed under the STOCK Act on July 2, 2026, the House Democrat executed the purchase quietly before disclosing it weeks later. The stock closed at $18.43 on the date of the transaction.

Inside Rep. Cisneros's KVUE Trade

The transaction report filed by the California lawmaker lists a purchase value range rather than an exact share count or dollar figure. Under congressional disclosure rules, stock transactions are reported within broad cash brackets, placing this acquisition in the $1,001 to $15,000 tier. The trade adds to a string of recent portfolio disclosures from Representative Cisneros following earlier filings for other publicly traded equities.

Other Institutional Activity in Kenvue

Pentwater Capital Management Lp reduced its holdings by 868,373 shares, ending with 51,130,000 shares worth about $966,868,292.0. Independent Franchise Partners, LLP grew its holdings by 1,220,350 shares, ending with 50,427,994 shares worth about $953,593,358.0. Massachusetts Financial Services Co. reduced its holdings by 5,029,198 shares, ending with 44,715,586 shares worth about $845,571,724.0.

Kenvue Inc. Stock Up 0.5%

Kenvue shares recently traded around $18.76 as of October 16, 2026, sitting up about 1.8% since the June trade. The stock holds a market capitalization of $36.3 billion and trades above its 50-day moving average of $18.34 and its 200-day moving average of $18.07.

Recent Earnings

The company generated $15.41 billion in trailing revenue with a net profit margin of 10.8% and a return on equity of 15.6%. Earnings per share over the trailing twelve months stand at $0.86. Kenvue is scheduled to release its next set of financial results on November 5, 2026.

Dividend

Kenvue pays an annual dividend rate of $0.84 per share, translating to a dividend yield of 4.44% based on recent trading levels. The dividend payout ratio sits at 96.5%.

Insider Buying and Selling at Kenvue Inc.

General Counsel Matthew Orlando sold 38,491 shares on May 8, 2026, at an average price of $17.66 for a total value of $679,691.0. Chief Financial Officer Heather Howlett sold 3,700 shares on June 10, 2026, at an average price of $18.10 for a total value of $66,988.0.

Wall Street Views on Kenvue

UBS maintained a Neutral rating on July 16, 2026, with a price target of $20.00. Barclays maintained an Equal-Weight rating on July 21, 2026, and raised its target from $18.00 to $19.00. UBS later maintained a Neutral rating on August 11, 2026, adjusting its price target from $20.00 to $19.00. The stock carries a consensus hold recommendation and a mean price target of $19.50 across 12 analyst opinions.

About Kenvue Inc.

Headquartered in Summit, New Jersey, Kenvue operates as a standalone consumer health business with well-known brands across self care, skin health, and essential health categories. The firm employs over 21,000 people globally and reaches consumers across North America, Europe, Asia, and Latin America.

Bottom Line

Investors tracking congressional trades will look to subsequent filing disclosures to see if Representative Cisneros adjusts his position further. The upcoming earnings report on November 5, 2026, will provide fresh insight into the company's financial health across its core segments.